DCs express a unique set of chemokines and chemokine receptors, maybe including XCR1 itself, that determines their function. It will be important to investigate how this new model for T cell help applies to other CD8+ T cell responses, including anti-tumor responses.
In this issue, Farez et al. report that the circadian hormone melatonin, whose levels vary with seasonal changes in night length, shifts the immune response toward an anti-inflammatory state that may explain the seasonal variability of multiple sclerosis disease activity.
An imbalance between the inflammatory and regulatory responses of the immune system can lead to chronic immune cell activation and autoimmunity. Mounting evidence implicates the Th17 subset of T helper cells, characterized by the production of the proinflammatory cytokine interleukin-17 (IL-17), with playing a central role in autoimmune diseases, including multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD) (Gaffen et al., 2014) . Predominantly located at barrier tissues that interface with the external world, Th17 cells maintain a high degree of flexibility to respond rapidly to constant fluctuations in environmental conditions and stimuli. The mechanisms that allow the adaptation of Th17 cells to the ever-changing environment include the ability to respond to changing nutrient status through the aryl hydrocarbon receptor (AHR) (Quintana et al., 2008) , to oxygen sensing pathways including HIF1a (Dang et al., 2011) , and to changes in osmotic pressure through serum/glucocorticoid regulated kinase 1 (SGK1) (Wu et al., 2013) . In this issue of Cell, Farez et al. (2015) uncover another environmental cueseasonal changes in daylight-that modulates the development of pathogenic Th17 cells. The daylight effect is mediated by the hormone melatonin, produced by the pineal gland and involved in the regulation of the circadian rhythm (Brzezinski, 1997) . Melatonin inhibits the development of proinflammatory Th17 cells and shifts the balance of the immune response toward immunosuppression.
It has been known for some time that the latitudinal gradient-the greater the distance from the equator-correlates with increasing occurrence of multiple sclerosis (Alonso and Herná n, 2008) . One of the phenomena linked to latitude is seasonal variation in exposure to UV radiation. There are convincing epidemiological data supporting the role of UV radiation-dependent vitamin D in reducing the disease course of MS (Munger et al., 2004 ). Yet, this correlation does not explain the increase in MS relapse rates during spring and summer months, when UV rays are most abundant. In order to understand the environmental factors impacting the seasonal pattern of MS relapses, Farez et al. (2015) hypothesize that melatonin production, which also follows seasonal variation, may be involved in MS disease. Following up on a cohort of MS patients, the authors identify a negative correlation between clinical relapse and melatonin levels, with the highest levels of melatonin and the lowest exacerbation rate during the winter months. Indeed, serum from relapsing-remitting MS patients shows a negative correlation between the levels of melatonin and the proinflammatory cytokine IL-17 and a positive correlation with the anti-inflammatory cytokine IL-10. In vitro, the addition of melatonin suppresses the polarization of human T helper cells into the Th17 lineage, resulting in diminished expression of the Th17 master transcription regulator RORC and production of IL-17. In addition to its negative impact on Th17 differentiation, melatonin also enhances the polarization of type 1 regulatory cells (Tr1), which can suppress immune responses through the production of IL-10. Through a series of carefully designed experiments with mice genetically deficient in different components along the melatonin signaling pathway, the authors find that melatonin-dependent reinforcement of NFIL3, a negative regulator of Rorc, suppresses the development of Th17 cell in murine cells, while activation of RORa boosts the Tr1cell fate.
Melatonin signals through the membrane melatonin receptor (MTNR1A) that is expressed on a variety of cell types, including T cells. Both melatonin and the small molecule agomelatine, a MTNR1A agonist, repress the differentiation of murine Th17 cells in vitro, resulting in the suppression of key Th17 signature genes, Rorc, Il17, and Il23r. Importantly, T cells from MTNR1A KO mice are resistant to the suppressive impact of melatonin in Th17 cell differentiation, arguing that the membrane melatonin receptor is critical to mediate the effects of melatonin in Th17 cell polarization. What is the molecular mechanism of melatonin-dependent inhibition of Th17 cells? The key to answering this question is based on a previous report (Yu et al., 2013) demonstrating an important contribution of REV-ERBa, a transcriptional repressor with key regulatory functions in the control of the circadian cycle, in promoting Th17 cell development, thus linking the circadian clock with Th17 cell development. Here is where the story gets complicated. Melatonin increases the activation of Erk 1/2 which in turn leads to an increase in the phosphorylation of the transcription factor C/EBPa. C/EBPa binds to the promoter of Nr1d1 (REV-ERBa) and acts as a negative regulator. Confirming the regulatory function of REV-ERBa in Nfil3, melatonin suppression of Nr1d1 expression results in increased NFIL3 binding to the Rorc promoter, leading to reduced expression of Rorc ( Figure 1A) . In a complementary set of experiments, the authors find that melatonin signaling also enhances in vitro Tr1 cell polarization, increases IL-10 production, and boosts the suppressive ability of these cells. Over the past 50 years, there has been a steady rise in the incidence of autoimmune diseases such as MS, RA, psoriasis, and IBD, particularly in developed countries. Recent studies have uncovered many environmental stress factors associated with the modern life contributing to the development of inflammatory disorders ( Figure 1B) . One example is the ''high-salt'' Western diet, where SGK1 on Th17 cells play a role in exacerbating T cell inflammatory mechanisms (Wu et al., 2013) . It is tempting to speculate whether the invention of artificial lights-which facilitates chronic circadian disruptions-could have contributed to an imbalance between the inflammatory and regulatory responses of the immune system, leading to immune dysregulation. The current study establishes a clear link between melatonin, a hormone involved in the regulation of the circadian rhythm, and the inhibition of proinflammatory Th17 cells, thereby shifting the balance of the immune response toward immunosuppression. These findings support the immunosuppressive properties of melatonin, as well as define the melatonin-NFIL3-RORgt pathway as a potential therapeutic target for the treatment of MS.
